The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Top Cited Papers
Open Access
- 1 April 2005
- journal article
- review article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 26 (2) , 251-282
- https://doi.org/10.1210/er.2004-0004
Abstract
The genetic mechanisms underlying functional hyperandrogenism and the polycystic ovary syndrome (PCOS) remain largely unknown. Given the large number of genetic variants found in association with these disorders, the emerging picture is that of a complex multigenic trait in which environmental influences play an important role in the expression of the hyperandrogenic phenotype.Among others, genomic variants in genes related to the regulation of androgen biosynthesis and function, insulin resistance, and the metabolic syndrome, and proinflammatory genotypes may be involved in the genetic predisposition to functional hyperandrogenism and PCOS.The elucidation of the molecular genetic basis of these disorders has been burdened by the heterogeneity in the diagnostic criteria used to define PCOS, the limited sample size of the studies conducted to date, and the lack of precision in the identification of ethnic and environmental factors that trigger the development of hyperandrogenic disorders. Progress in this area requires adequately sized multicenter collaborative studies after standardization of the diagnostic criteria used to classify hyperandrogenic patients, in whom modifying environmental factors such as ethnicity, diet, and lifestyle are identified with precision.In addition to classic molecular genetic techniques such as linkage analysis in the form of a whole-genome scan and large case-control studies, promising genomic and proteomic approaches will be paramount to our understanding of the pathogenesis of functional hyperandrogenism and PCOS, allowing a more precise prevention, diagnosis, and treatment of these prevalent disorders.Keywords
This publication has 292 references indexed in Scilit:
- Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish womenFertility and Sterility, 2002
- Association of AccI polymorphism in the follicle-stimulating hormone β gene with polycystic ovary syndromeFertility and Sterility, 2000
- No association between body mass index and β3-adrenergic receptor variant (W64R) in children with premature pubarche and adolescent girls with hyperandrogenismFertility and Sterility, 2000
- Role of the mutations Trp8 ⇒ Arg and Ile15 ⇒ Thr of the human luteinizing hormone β-subunit in women with polycystic ovary syndromeFertility and Sterility, 1999
- Polymorphism T→C (−34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndromeFertility and Sterility, 1999
- Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-α?Atherosclerosis, 1999
- Lack of an ovarian function influence on the increased adrenal androgen secretion present in women with functional ovarian hyperandrogenismFertility and Sterility, 1997
- Antigenic Alteration of an Anomalous Human Luteinizing Hormone Caused by Two Chorionic Gonadotropin-Type Amino-Acid SubstitutionsBiochemical and Biophysical Research Communications, 1994
- Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groupsGenomics, 1992
- Stone agers in the fast lane: Chronic degenerative diseases in evolutionary perspectivePublished by Elsevier ,1988